Atashbasteh Mostafa, Mortaz Esmaeil, Mahdaviani Seyed Alireza, Jamaati Hamidreza, Allameh Abdolamir
Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Allergy Asthma Clin Immunol. 2021 May 17;17(1):51. doi: 10.1186/s13223-021-00556-z.
Identification of molecular markers, such as miRNAs is promising for the diagnosis of asthma and its clinical phenotypes. The aim of this study was to examine the changes in the expression of selected microRNAs in plasma exosomal fractions of severe asthma patients. The expression of miRNAs was determined in relation to the changes in inflammatory markers.
Severe asthma patients (n = 30) and healthy subjects (n = 30) were selected among the individuals referred to asthma and allergy clinic. Blood was collected from each participant to determine the serum high-sensitive C-reactive protein (hs-CRP) and total IgE. The exosomal fraction of plasma was isolated and processed for quantitation of miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p expression using quantitative real time-PCR (qRT-PCR).
Serum hs-CRP and total IgE were significantly higher in asthma patients compared to controls. Expression of miR-124, miR-133b, and miR-130a was down-regulated in asthma patients as compared to controls (p < 0.0001). However, the expression of miR-125b was substantially higher in patients compared to controls (p < 0.0001). There was no significant difference in the expression of miR-125b-1-3p in the patients and controls. Data analysis revealed that among the miRNAs, changes in miR-125b in severe asthma patients were highly correlated with the serum levels of hs-CRP and IgE.
Overexpression of miR-125b in severe asthma which was associated with serum IgE and hs-CRP may suggest that this molecule is linked to inflammatory reactions. Up-regulation of miR-125b together with decreased expression of miR-124, miR-133b, and miR-130a may suggest that this miRNA profile is useful for diagnosis and discrimination of clinical phenotypes of asthma.
鉴定诸如微小RNA(miRNAs)等分子标志物,对于哮喘及其临床表型的诊断具有重要意义。本研究旨在检测重度哮喘患者血浆外泌体组分中所选微小RNA表达的变化,并确定微小RNA的表达与炎症标志物变化之间的关系。
从哮喘与过敏门诊的患者中选取重度哮喘患者(n = 30)和健康受试者(n = 30)。采集每位参与者的血液,以测定血清高敏C反应蛋白(hs-CRP)和总IgE。分离血浆的外泌体组分,并使用定量实时聚合酶链反应(qRT-PCR)对miR-124、miR-125b、miR-133b、miR-130a和miR-125b-1-3p的表达进行定量分析。
与对照组相比,哮喘患者的血清hs-CRP和总IgE显著更高。与对照组相比,哮喘患者中miR-124、miR-133b和miR-130a的表达下调(p < 0.0001)。然而,与对照组相比,患者中miR-125b的表达显著更高(p < 0.0001)。患者与对照组中miR-125b-1-3p的表达无显著差异。数据分析显示,在这些微小RNA中,重度哮喘患者中miR-125b的变化与hs-CRP和IgE的血清水平高度相关。
重度哮喘中miR-125b的过表达与血清IgE和hs-CRP相关,这可能表明该分子与炎症反应有关。miR-125b的上调以及miR-124、miR-133b和miR-130a表达的降低可能表明这种微小RNA谱有助于哮喘临床表型的诊断和鉴别。